Module 5 Flashcards

1
Q

Hypertensive disorders of pregnancy

A

pre-existing HTN (essential vs. secondary)
gestational HTN
pre-eclampsia
severe pre-eclampsia
eclampsia
HELLP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

gestational HTN

A

occurs after 20 weeks
1) with proteinuria (with or without adverse conditions)
2) without proteinuria (with or without adverse conditions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pre-eclampsia

A

HTN + proteinuria (+1 or greater) OR end-organ dysfunction OR severe consequences (eclampsia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

RF for HTN in pregnancy

A

family hx
extremes of reproductive age (<20 or >35)
primigravida
multiple gestation
diabetes, renal dx, prior HTN
collagen vascular dx
no mid-trimester fall in BPO
excessive weight gain (>2 lb/week)
finger/facial edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Patho of pre-eclampsia

A

poor placentation
first stage: cytotrophoblast invades endometrium & remodels spiral arteries
second stage: cytotrophoblast invades myometrium & remodels arteries –> wider, low pressure system

pre-eclampsia occurs when this remodeling does not occur. placental ischemia –> release of inflammatory cytokines/factors that get released into maternal circulation and cause endothelial dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Adverse outcomes of pre-eclampsia

A

vascular remodeling/endothelial vasospasm = HTN
kidney damage = proteinuria, liver damage = elevated enzymes
RBC traveling through damaged blood vessels sheared = hemolysis
clotting activated by endothelial injury/turbulent blood flow thrombocytopenia s/t systemic clotting –> DIC edema (increased capillary permeability)
eclampsia/headache/hemiplegia/visual disturbance (cerebral vasospasm)
cardiomyopathy
ARDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nursing mgmt of pre-eclampsia

A

bed rest
fetal assessment (ultrasound/nonstress test)
weight gain
blood pressure measurements
proteinuria
fetal movement
general symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Severe pre-eclampsia

A

gestational HTN with or without proteinuria with 1+ adverse conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Severe pre-eclampsia adverse conditions

A

severe N/V
frontal headache
visual disturbance
epigastric/RUQ pain
chest pain
SOB
leukocytosis
abnormal coagulation
thrombocytopenia
increased creatinine/uric aid
increased liver enzymes (AST, ALT, LDH, bili)
decreased albumin
fetoplacental (abnormal FHR, IUGR, oligohydramnios, absent/reversed end-diastolic flow)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Maternal signs of severe pre-clampsia

A

DBP > 110
oliguria <500/day
pulmonary edema
suspected abruptio placenta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Maternal labs for severe pre-eclampsia

A

platelets <100
elevated liver enzymes (AST/ALT)
plasma albumin <18
heavy proteinuria 3+ or greater

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fetal signs of severe pre-eclampsia

A

IUGR
oligohydramnios
absent/reversed end diastolic flow of doppler

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

S/S of eclampsia

A

**often not observed prior to seizures

severe headache/occipital headache
brisk reflexes
visual disturbances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Severe pre-eclampsia treatment

A

1:1 nursing
calm, quiet environment
transfer to specialized unit
increased monitoring (HR/BP Q15min/4 hours until stabilized –> Q30min)
oral HTN medication
IV insertion
indwelling catheter (monitor output)
proteinuria testing
I&O documentation
O2 supplementation
VTE prophylaxis
seizure precautions (padded rails)
ensue calcium gluconate/maternal resuscitation equipment ready

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pharmacologic management of severe pre-eclampsia

A

nifedipine (CCB)
labetolol (beta blocker)
hydralazine (vasodilator)
methyldopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Magnesium sulfate

A

seizure prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Magnesium sulfate MOA

A

decreases CNS irritability
blocks Ach release –> blocking neuromuscular conduction
relaxes smooth muscle of uterus (competes w/ calcium)
peripheral vasodilation
increased uterine/renal perfusion
increased prostacyclin from endothelial cells (vasodilation)
reduced platelet aggregation
inhibits RAAS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Magnesium sulfate antidote

A

calcium gluconate IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Magnesium sulfate side effects

A

flushing of skin
hypotension
metallic taste
N/V
palpitations
sweating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Magnesium sulfate toxicity

A

absent deep tendon reflexes
cardiac arrhythmia
CNS depression
excessive drowsiness
muscle weakness, ataxia
respiraotry depression (<12)
slurred speech
hypocalcemia + tetany (competes with calcium which is needed for muscle contraction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Eclampsia

A

new onset generalized tonic-clonic seizures assoc w/ pre-eclampsia
can occur up to 24 hours postpartum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Gestational diabetes

A

insulin resistance –> diabetes after 20 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Human placental lactogen

A

produced ~6-30 weeks
antagonist to insulin
increases insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

GDM & fetal development

A

macrosomia (>90th percentile)
hyperinsulinemia = decreased surfactant production
increased fetal BMR = fetal hypoxemia = metabolic acidosis
increased erythropoiesis = polycythemia = decreased iron for developing organs = cardiomyopathy, altered neurodevelopment, cardiac remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
RF for GDM
age >25 non-white people PCOS (higher testosterone) HTN multiple gestation family hx previous macrosomia
26
Maternal complications of GDM
increased r/o HTN/pre-eclampsia polyhydramnios increased r/o future T2DM
27
Fetal complications of GDM
macrosomia hypoglycemia respiratory distress syndrome hyperbilirubinemia stillbirth future obesity
28
HDN
hemolytic anemia caused by isoimmunization maternal IgG antibodies attack fetal RBC d/t incompatibility of surface antigens
29
Types of blood incompatibility
ABO RH
30
ABO incompatibility
mild usually resolves on its own dose not typically result in severe hyperbilirubinemia **most common with O- mom
31
Rh- incompatibility
caused by Rh- mom & Rh+ baby first pregnancy: maternal IgG antibodies form when mom blood exposed to fetal blood second pregnancy: maternal IgG antibodies attack fetal RBC
32
HDN treatment
rhogam (prevention) phototherapy exchange transfusion IV immunoglobulin (reduces hemolysis) centesis for hydrops fetalis in utero RBC transfusion
33
When is rhogam given
28 days 72 hours after birth
34
Causes of maternal sensitization (HDN)
normal delivery spontaneous/induced abortion chorionic villlus sampling amniocentesis prenatal hemorrhage maternal trauma idiopathic **only .1 mL needed to activate maternal immune response
35
HDN complications
anemia hyperbilirubinemia kernicterus growth restriction hydrops fetalis
36
HDN complications
hyperbilirubinemia --> acute encephalopathy/kernicterus symptomatic anemia (pallor, lethargy, tachycardia, tachypnea) hydrops fetalis IUGR
37
HDN tests
DAT (coombs test) measures IgG antibodise cord blood IAT CBC TCB/serum bili peripheral blood smear
38
Maternal hormones that act as insulin antagonists
human sommatotropic hormone (human placental lactogen) estrogen progseterone prolactin cortisol insulinase (degrading enzyme)
39
When does fetus begin secreting insulin
10-14 weeks gestation
40
Hypoglycemia in pregnancy
<3.2 mmol
41
Pharmacotherapy GDM
insulin (first-line, doesn't cross placenta) metformin (may cross placenta) glyburide (last resort if intolerant to metformin & refusing insulin)
42
Hyperglycemia in pregnancy
>11
43
Target blood glucose levels in pregnancy
3.8-5.2 (S/S of hypoglycemia may present at <3.8)
44
Fetal consequences of GDM
hyperinsulinemia --> decreased surfactant/lung maturation, increased growth (macrosomia) increased O2 demand = increased erythropoiesis = decreased iron (cardiac myopathy/impaired neural development), increased r/o jaundice abnormal placenta --> preterm, IUGR perinatal asphyxia/hypoglycemia upon birth neonatal respiratory distress syndrome
44
Maternal consequences of GDM
higher longterm r/o of T2DM DKA macrosomia --> dystocia --> C/S or hemorrhage pre-eclampsia/HTN infection hypoglycemia (higher risk in early 1-2 trimesters as insulin need decreases)
45
GDDC
gestational diabetes diet controlled low glycemic diet exercise (30 min/daily) decreased fat/carbs
46
GDID
gestational diabetes insulin dependent insulin indicated when glucose targets cannot be maintained on diet/exercise alone
47
Blood glucose targets in pregnancy
FBG <5.3 1 hour postprandial <7.8 2 hours postprandial <6.7
48
Ferritin target in pregnancy
>15
49
Hemoglobin target in pregnancy
>105
50
Entonox
nitrous oxide
51
Stages of PPH
Stage 1 Stage 2 Stage 3
52
Stage 1 PPH
>500 SVD or >1000 CS with continued bleeding + HR higher than SBP
53
Stage 2 PPH
1000-1500 and HR higher than SBP
54
Stage 3 PPH
>1500 blood loss or hemodynamically unstable anticipated need for 3+ PRBCwithin 1 H or fibrinogen level <2.5 g/L
55
S/S of neonatal adaptation syndrome
**caused by exposure to SSRI/SNRi in utero respiratory distress feeding difficulty jitteriness irritabiilty temperature instability sleep problems tremors shivering restlessness convulsions jaundice rigidity hypoglycemia
56
Onset of NAS
0-3 days duration 2 weeks
57
NAS interventions
quiet, low-light enivronment STS if s/s toxicity present: respiratory support fluid replacement anticonvulsant therapy
58
Persistent pulmonary hypertension
failure of pulmonary vasculature to relax after extrauterine transition --> right-to-left shunting of blood thru fetal circulatory pathways can cause hypoxemia refractory to treatment
59
SSRI newborn complications
neonatal adaptation syndrome congenital heart defects persistent pulmonary hypertension
60
is breastfeeding contraindicated with SSRIs?
no
61
NESTS self-care acronym
nutritious food exercise (daily) sleep time for self-care support